Author

Jorge Duconge

University of Puerto Rico Medical Sciences Campus - Cited by 1,741 - Pharmacogenomics - Precision Medicine - Pharmacokinetics

Biography

Dr. Duconge is Associate Professor in the Pharmaceutical Sciences Department at the University of Puerto Rico School of Pharmacy. He earned his PhD degree at the University of Havana, Cuba. He has teaching experience of more than 13 years in Pharmacokinetics, Biopharmaceutics and Pharmacogenomics.  Current research interest and expertise is in the area of pharmacogenomics and DNA-guided personalized medicine 
Title
Cited by
Year
PharmVar GeneFocus: CYP2C19
MR Botton, M Whirl‐Carrillo, AL Del Tredici, K Sangkuhl, LH Cavallari, ...Clinical Pharmacology & Therapeutics 109 (2), 352-366, 2021202
69
2021
Genetic factors influencing warfarin dose in Black‐African patients: a systematic review and meta‐analysis
IG Asiimwe, EJ Zhang, R Osanlou, A Krause, C Dillon, G Suarez‐Kurtz, ...Clinical Pharmacology & Therapeutics 107 (6), 1420-13, 2020202
43
2020
PharmVar GeneFocus: CYP2C9
K Sangkuhl, K Claudio‐Campos, LH Cavallari, JAG Agundez, ...Clinical Pharmacology & Therapeutics 110 (3), 662-676, 2021202
31
2021
Machine learning algorithm for predicting warfarin dose in caribbean hispanics using pharmacogenetic data
A Roche-Lima, A Roman-Santiago, R Feliu-Maldonado, ...Frontiers in pharmacology 10, 1550, 2020202
19
2020
Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations
JS Graydon, K Claudio, S Baker, M Kocherla, M Ferreira, A Roche-Lima, ...Biomarkers in Medicine (8), 649-661, 2019201
13
2019
Efficacy of rac and Cdc42 inhibitor MBQ-167 in triple-negative breast cancer
A Cruz-Collazo, JF Ruiz-Calderon, H Picon, LD Borrero-Garcia, I Lopez, ...Molecular cancer therapeutics 20 (), 2420-2432, 2021202
12
2021
A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
HA Seguí, K Melin, DS Quiñones, J DucongeJournal of translational genetics and genomics 4, 263, 2020202
12
2020
Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry
MM Maldonado, G Rosado-González, J Bloom, J Duconge, ...ACS omega 4 (19), 17981-17989, 2019201
11
2019
Personalized health and the coronavirus vaccines—Do individual genetics matter?
BN Valdés‐Fernández, J Duconge, AM Espino, G RuañoBioEssays 43 (9), 20087, 2021202
10
2021
Machine learning for prediction of stable warfarin dose in US Latinos and Latin Americans
HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ...Frontiers in Pharmacology 12, 74976, 2021202
8
2021
Physiologically-based pharmacokinetic/pharmacodynamic model of MBQ-167 to predict tumor growth inhibition in mice
J Reig-López, MM Maldonado, M Merino-Sanjuan, AM Cruz-Collazo, ...Pharmaceutics 12 (10), 975, 2020202
8
2020
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
J Duconge, E Santiago, DF Hernandez‐Suarez, M Moneró, ...Clinical and Translational Science 14 (6), 2254-2266, 2021202
7
2021
Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service
I Rodríguez‐Escudero, JA Cedeño, I Rodríguez‐Nazario, ...Journal of the American College of Clinical Pharmacy 3 (6), 1028-103, 2020202
7
2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
DF Hernandez-Suarez, K Melin, F Marin-Maldonado, HJ Nunez, ...BMJ open 10 (8), e038936, 2020202
7
2020
Solubility Determination and Correlation of Warfarin Sodium 2-Propanol Solvate in Pure, Binary, and Ternary Solvent Mixtures
MV George De la Rosa, R Santiago, J Malavé Romero, J Duconge, ...Journal of Chemical & Engineering Data 4 (4), 1399-1413, 2019201
6
2019
Low-frequency variants at the CYP2C9 locus among Puerto Rican patients on warfarin: in silico predictions of functionality and conservation
K Claudio-Campos, M Moneró-Paredes, E Hernández, J Renta, ...Pharmacogenomics 20 (12), 891-902, 2019201
5
2019
Pharmacokinetic characterization and external evaluation of a quantitative framework of sublingual buprenorphine in patients with an opioid disorder in Puerto Rico
D Santiago, V Mangas-Sanjuan, K Melin, J Duconge, W Zhao, ...Pharmaceutics 12 (12), 1226, 2020202
5
2020
Multi‐site investigation of genetic determinants of warfarin dose variability in Latinos
N El Rouby, L Rodrigues Marcatto, K Claudio, L Camargo Tavares, ...Clinical and Translational Science 14 (1), 268-276, 2021202
5
2021
CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements
KI Claudio-Campos, P González-Santiago, JY Renta, J Rodríguez, ...Pharmacogenomics 20 (01), 3-8, 2019201
5
2019
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort
K Melin, JY Moon, Q Qi, DF Hernandez-Suarez, J Duconge, S Hua, ...Pharmacogenomics 20 (02), 75-8, 2019201
3
2019

Referred From: https://scholar.google.com/citations?user=HoJp4jAAAAAJ&hl=en

Cited by
Citations 1741
h-index 22
i10-index 55
Recommended Journals
Open Access Journals